The race to commercialize MRAM has entered the home stretch.Whoâs going to come in first, whoâs going to profit, and how is it all going to affect the landscape of nanotech investment? We remain confident of NVEâs prospects despite some vocal detractors of NVEC, and a few investment firms are beginning to wake up to this potential.
Posted: Nov 24,2004 by Ron Mertens
